Sat.May 21, 2022 - Fri.May 27, 2022

article thumbnail

How to Succeed in Pharmacy School

Find Your Script

Are you a student entering pharmacy school? In this video, I’ll talk about my 4 steps to have success in pharmacy school. Stay until the end for my most important step. Watch & Subscribe on our YouTube Channel ! [link]. Hi, I’m Dr. Jessica Louie and I’m an Associate Professor, Board-Certified Critical Care Pharmacist and entrepreneur. I help people find meaning beyond a job title and let go of burnout.

article thumbnail

Find your inner data and take precision marketing to the next level

pharmaphorum

Data is the powerhouse of the pharmaceutical sector. It powers drug discovery, clinical trials, and operational performance. But sizeable reservoirs of data remain unseen and untapped to commercial operations, allowing insights, opportunities, and efficiencies to leak away. Organisations are missing out on the ability to harness their data to energise precision marketing and transform commercial performance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Go With A PCD Pharma Franchise Company?

Fossil Remedies

Are you going to launch a new business by partnering with a new PCD Pharma Company ? Or do you want to expand your business by adding one more company? In both situations, you should be careful and selective while choosing a company. There are several companies around when you search for it. But it is always good to associate with the best one. Why should you prefer the best company?

article thumbnail

Standigm uses AI to discover potential Crohn’s disease treatment

Outsourcing Pharma

The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohnâs.

91
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

AstraZeneca kidney inflammation treatment trial reaches dosing stage

Pharma Times

Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis

58
article thumbnail

Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

pharmaphorum

The move to online international meetings has left pharma companies with uncertainty around contact compliance. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. Since COVID-19 reared its head more than two years ago, the traditional hustle and bustle of in-person annual congresses have largely been consigned to the history books.

More Trending

article thumbnail

Lithuanian CDMO to open facility in Boston

Outsourcing Pharma

Northway Biotech, a contract development and manufacturing organization (CDMO) based out of Vilnius, Lithuania, is set to open a facility in Boston, US.

59
article thumbnail

Alternative to open heart surgery emerges following NIHR research

Pharma Times

Less invasive procedure offers an equally effective alternative for heart condition patients

56
article thumbnail

PTC gets green light for gene therapy Upstaza in EU

pharmaphorum

PTC Therapeutic’s Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for gene therapies in the bloc. Once full approval is granted Upstaza (eladocagene exuparvovec) will become the first disease-modifying treatment for AADC (aromatic L-amino acid decarboxylase) deficiency, as well as the first gene therapy directly administered into the brain, said PTC.

101
101
article thumbnail

Events and training for pharmaceutical microbiologists 2022

Pharmig

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post Events and training for pharmaceutical microbiologists 2022 appeared first on Pharmig.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Prioritizing Self-Care in Healthcare 

Board Vitals - Pharmacist

Physicians and other healthcare professionals are trained to care for others. It’s what we do. In dedicating our lives to caring for others, self-care comes last, and we often put ourselves on the back burner. During training, and in our careers, the default mode is that our own needs come last. That’s embedded into our medical culture. . What if we shifted our focus and treated ourselves as well as we treat those who we love most in the world?

52
article thumbnail

PTC Therapeutic’s Upstaza has been recommended by both the EMA and CHMP

Pharma Times

It is the first gene therapy to be directly administered into the brain to treat aromatic L-amino acid decarboxylase (AADC) deficiency

52
article thumbnail

Taking patient engagement efforts beyond box-ticking

pharmaphorum

Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do. But for many, it is a prospect that remains much easier said than done. A lack of defined processes for the collection and sharing of insights across the drug development cycle has hampered the industry’s good intentions and, in some cases, turned engagement into an empty box-ticking exercise.

98
article thumbnail

Syneos Health promotes industry veteran to CEO

Outsourcing Pharma

Michelle Keefe, formerly the president of medical affairs and commercial solutions, joined the company in 2017; she also had spent 20 years working for Pfizer.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data Video

Pharma Marketing Network

Tune in to this episode of the Pharma Marketing Podcast with Bharti Rai, Novartis VP, Chief Commercial Operations, Insight, Analytics Officer Data & Digital, for a deeper dive into what’s ahead for 1st and 3rd party data, insights, analytics & digital data. The post What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data Video appeared first on Pharma Marketing Network.

52
article thumbnail

EC approves Janssen T-cell therapy for multiple myeloma treatment

Pharma Times

Approval provides another step forward in transforming multiple myeloma outcomes and eliminating the disease

51
article thumbnail

Pay deal averts strike action at GSK’s UK sites

pharmaphorum

Industrial action at several GlaxoSmithKline manufacturing plants in the UK has been called off, after an improved pay deal was accepted by the Unite union. Unite said last month it was calling for strike by GSK workers for the first time in the company’s history, saying a “derisory” 2.75% pay increase was in fact a pay cut in real terms given the rising rate of inflation in the UK, currently at around 9%.

98
article thumbnail

Digital health initiative offers resources to increase inclusivity

Outsourcing Pharma

The DATAcc has released a collection of open-access resources that are intended to help users build inclusivity into digital health measurement products.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Bharti Rai, Novartis VP & Head of Commercial Acceleration on What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data

Pharma Marketing Network

Tune in to this episode of the Pharma Marketing Podcast with Bharti Rai, Novartis VP, Chief Commercial Operations, Insight, Analytics Officer Data & Digital, for a deeper dive into what’s ahead for 1st and 3rd party data, insights, analytics & digital data. The post Bharti Rai, Novartis VP & Head of Commercial Acceleration on What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data appeared first on Pharma Marketing Network.

52
article thumbnail

Thousands to potentially benefit from Roche treatment for sight loss

Pharma Times

Faricimab is administered as an eye injection with an interval of up to 16 weeks

49
article thumbnail

Akili partners with gaming giant Roblox on ADHD therapy delivery

pharmaphorum

Digital health company Akili Interactive has agreed a deal that could see its gamified therapy for attention-deficit hyperactivity disorder (ADHD) hosted on the creative gaming platform Roblox, used by around 55 million users worldwide. First launched in 2006, Roblox is an online space where users can play games – more than 20 million of them at a recent count – created by developers and individuals.

FDA 93
article thumbnail

ObvioHealth digital tools aim to bring objectivity to pediatric clinical trial assessments

Outsourcing Pharma

The virtual research organization has developed digital instruments designed for assessing stools and recording crying episodes in pediatric clinical studies.

52
article thumbnail

eBook: Predictions and trends 2022

Pharma Manufacturing

While change does not always happen quickly in the pharma industry, the ongoing global pandemic has quickened the pace of emerging trends.

45
article thumbnail

Cumulus Neuroscience begins studies of digital biomarker

Pharma Times

Technology is already being used in clinical trials of new treatments for Alzheimer’s and new studies will provide additional validation

49
article thumbnail

Takeda, Daiichi-backed wearable study planned in Japan

pharmaphorum

A study that will look at the feasibility of tracking people’s lifestyle habits for an extended period using a wearable device has got underway in Japan, backed by drugmakers Takeda and Daiichi Sankyo. The device will be worn by 2,000 people for a year, harvesting data on sleep status, heart rate, and activity levels, according to the study partners, which also include digital health and telemedicine firm MICIN and Tohoku University.

90
article thumbnail

Virtual care tech firm Biofourmis lands $300m vote of confidence

Outsourcing Pharma

The digital medicine solutions developer has received $300m in a Series D investment round, which will be used to help scale up its virtual care offerings.

52
article thumbnail

eBook: Facility trends 2022

Pharma Manufacturing

With utility costs on the rise, many pharma manufacturers are taking a closer look at their facilities and finding that better facility design, resource management and maintenance strategies can offer sources of overlooked savings, as well as opportunities for sustainability.

40
article thumbnail

NICE recommendation for Sanofi and Regeneron’s CSCC treatment

Pharma Times

Libtayo has been approved for adults when curative surgery or radiation is not appropriate

49
article thumbnail

Amwell’s SilverCloud buy yields new digital tool for mental health

pharmaphorum

Telehealth company Amwell has marked Mental Health Awareness month with the launch of a digital tool that will deliver cognitive behavioural health interventions across a spectrum of mental illness. The suite – which combines virtual therapy and psychiatry, optional coaching, and digital mental health programmes tailored to the patient’s needs – has been developed in the wake of Amwell’s acquisition last year of SilverCloud Health.

87
article thumbnail

Dermatology drug developer taps into Veeva engagement tool

Outsourcing Pharma

With Veeva Link for Key People, LEO Pharma is looking to deepen its efforts to engage with knowledgeable medical professionals in the dermatology community.

52
article thumbnail

eBook: Contract manufacturing trends (Spring 2022)

Pharma Manufacturing

New, complex therapies coming through the pharma pipelines are putting immense pressure on supply chains and manufacturing capacity, challenging traditional scale-up and manufacturing processes at the same time — and CDMOs have stepped up into the thick of it all.

40
article thumbnail

CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD

Pharma Times

Positive opinion is based on data from clinical trials which showed improvement in lung function

49
article thumbnail

Roche trumpets new glofitamab data in lymphoma at ASCO

pharmaphorum

Roche will present the new data at next week’s ASCO congress showing that its bispecific antibody glofitamab can achieve high and durable responses in patients with aggressive lymphoma. The results of the phase 2 NP30179 study will be presented for the first time at ASCO, involving 107 patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who had received a median of three prior therapies.

69